(Q38361912)

2 September 2017

title

Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents (English)

1 reference

2 September 2017

3

Ryszard Kole

1 reference

2 September 2017

author name string

Danielle R Mercatante

series ordinal

1

1 reference

2 September 2017

James L Mohler

series ordinal

2

1 reference

2 September 2017

language of work or name

English

0 references

publication date

14 October 2002

1 reference

Journal of Biological Chemistry

2 September 2017

published in

1 reference

2 September 2017

volume

277

1 reference

2 September 2017

issue

51

1 reference

2 September 2017

page(s)

49374-49382

1 reference

Targeting cancer cell death with a bcl-XS adenovirus

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Apoptosis and cancer drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Dysregulation of apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Bcl-X(L) antisense sensitizes human colon cancer cell line to 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Inhibition of Bcl-xL expression sensitizes T-cell acute lymphoblastic leukemia cells to chemotherapeutic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

A recombinant bcl-x s adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Bcl-x(S) anatagonizes the protective effects of Bcl-x(L).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Cytochrome c depletion upon expression of Bcl-XS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Cell-cycle arrest and p53-independent induction of apoptosis in vitro by the new anticancer drugs 5-FdUrd-P-FdCydOct and dCydPam-P-FdUrd in DU-145 human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

p53 oncogene mutations in three human prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Pitx2a expression alters actin-myosin cytoskeleton and migration of HeLa cells through Rho GTPase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Sensitivity of splice sites to antisense oligonucleotides in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Role of Bcl-2 family proteins (Bax, Bcl-2 and Bcl-X) on cellular susceptibility to radiation in pancreatic cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Buthionine sulphoximine-mediated sensitisation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Induction of apoptosis in lung-cancer cells following bcl-xL anti-sense treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Bcl-x(L) antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

In vivo suppression of Bcl-XL expression facilitates chemotherapy-induced leukaemia cell death in a SCID/NOD-Hu model

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Targeting tumor cell resistance to apoptosis induction with antisense oligonucleotides: progress and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Novel therapeutic strategy for advanced prostate cancer using antisense oligodeoxynucleotides targeting anti-apoptotic genes upregulated after androgen withdrawal to delay androgen-independent progression and enhance chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

An alternative molecular mechanism of action of 5-fluorouracil, a potent anticancer drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Unwinding the loop of Bcl-2 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Basis for effective combination cancer chemotherapy with antimetabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

In vitro schedule-dependent interaction between paclitaxel and cisplatin in human carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: effects on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Evaluating the specificity of antisense oligonucleotide conjugates. A DNA array analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Antisense DNAs as multisite genomic modulators identified by DNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

Chemotherapy-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M209236200

21 January 2018

Identifiers

DOI

10.1074/JBC.M209236200

1 reference

release_6vigizaiy5hjndpdmbono7uajy

2 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6vigizaiy5hjndpdmbono7uajy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference